Airway Maintenance
In treating this severe and very rare genetic
skin disorder (harlequin ichthyosis) upon delivery, the baby’s airway and
circulation is the foremost priority. The healthcare team must ensure that the baby’s/patient's
airway, breathing, and circulation are in stable condition after delivery. The baby
will require intravenous access. It will be through the access where the
medication will be given. Peripheral access may be difficult. Umbilical
cannulation may be necessary. The infant must be placed in a humidified
incubator, the temperature, respiratory rate, heart rate and oxygen saturation
must be monitored by the healthcare team. Once the vital sign have stabilized
the baby is then transferred into a level 3 neonatal nursery station or room.
Projection of Conjunctiva
Expose keratitis results from ectropian of the eye-side. It is
necessary to apply ophthalmic lubricants frequently to protect the
conjunctivae. It is advisable to bathe the infants twice daily and use frequent
wet sodium chloride compresses
followed by application of bland lubricants to soften hard skin. Topical
keratolytics (eg, salicylic acid) are not recommended in newborns because of
potential systemic toxicity.
Intravenous Access for Feeding
It is prescribed to have intravenous access for intravenous
fluids as it is almost always required. Neonates with harlequin ichthyosis
initially do not feed well. There is a need to calculate daily fluid
requirements since the neonates will experience excess cutaneous water losses. In
addition to that, monitoring of serum electrolyte levels is required. There also
having a high risk of hypernatremic
dehydration.
Sterile Environment
The sterile environment has to be always maintained
to avoid infection. Frequent cultures of the skin should be taken. Growth of
pathogenic organisms (eg, Staphylococcus aureus, Pseudomonas aeruginosa)
indicates risk of sepsis. The blood culture has to be drawn as sepsis can occur
quickly in affected infants. A consensus does not exist regarding the use of
prophylactic antibiotics in these patients.
No comments:
Post a Comment